Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

RTOG Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.rtog.org

Clinical Trials

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Phase 3

Completed

Conditions: Prostate Cancer

Interventions: Drug: Oral antiandrogen
Drug: Dexamethasone
Radiation: Radiation therapy
Drug: Prednisone
Drug: LHRH agonist
Drug: docetaxel

First Posted Date: 2006-02-07

Last Posted Date: 2022-06-21

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 612

Registration Number: NCT00288080

Locations: 🇺🇸
UAB Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Providence Cancer Center, Anchorage, Alaska, United States
🇺🇸
Arizona Oncology Services Foundation, Phoenix, Arizona, United States

and more 251 locations

Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase 3

Completed

Conditions: Head and Neck Cancer

Interventions: Drug: cisplatin
Drug: cetuximab
Radiation: Accelerated Fractionation by Concomitant Boost
Radiation: Intensity-modulated radiation therapy

First Posted Date: 2005-12-15

Last Posted Date: 2022-06-14

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 940

Registration Number: NCT00265941

Locations: 🇺🇸
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham, Alabama, United States
🇺🇸
Providence Cancer Center, Anchorage, Alaska, United States
🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States

and more 366 locations

Radiation Therapy in Treating Patients With Liver Metastases

Phase 1

Completed

Conditions: Metastatic Cancer

First Posted Date: 2005-11-21

Last Posted Date: 2015-11-17

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 26

Registration Number: NCT00255814

Locations: 🇺🇸
James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States
🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
🇨🇦
McGill Cancer Centre at McGill University, Montreal, Quebec, Canada

Temozolomide and Radiation Therapy in Treating Patients With Gliomas

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Drug: Temozolomide
Radiation: Radiation therapy

First Posted Date: 2005-06-14

Last Posted Date: 2024-07-08

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 136

Registration Number: NCT00114140

Locations: 🇺🇸
Arizona Oncology Services Foundation, Phoenix, Arizona, United States
🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
🇺🇸
CCOP - Christiana Care Health Services, Newark, Delaware, United States

and more 44 locations

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Phase 3

Terminated

Conditions: Head and Neck Cancer

Interventions: Drug: cisplatin
Biological: filgrastim
Drug: docetaxel
Drug: paclitaxel
Drug: fluorouracil
Radiation: radiation therapy

First Posted Date: 2005-06-08

Last Posted Date: 2013-07-02

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 15

Registration Number: NCT00113399

Locations: 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Mobile Infirmary Medical Center, Mobile, Alabama, United States
🇺🇸
St. Joseph's Mercy Cancer Center, Hot Springs, Arkansas, United States

and more 122 locations

Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer

Phase 3

Terminated

Conditions: Lung Cancer

Interventions: Biological: filgrastim
Biological: pegfilgrastim
Drug: cisplatin
Drug: docetaxel
Procedure: adjuvant therapy
Procedure: conventional surgery
Procedure: neoadjuvant therapy
Radiation: radiation therapy

First Posted Date: 2005-06-08

Last Posted Date: 2013-06-28

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 19

Registration Number: NCT00113386

Locations: 🇺🇸
Cancer Center at Providence Alaska Medical Center, Anchorage, Alaska, United States
🇺🇸
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸
Cancer Care Center at John Muir Health - Concord Campus, Concord, California, United States

and more 73 locations

Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Drug: irinotecan hydrochloride
Drug: temozolomide
Procedure: adjuvant therapy
Radiation: radiation therapy

First Posted Date: 2004-12-09

Last Posted Date: 2014-01-24

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 170

Registration Number: NCT00099125

Locations: 🇺🇸
Foundation for Cancer Research and Education, Phoenix, Arizona, United States
🇺🇸
Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States
🇺🇸
Saint Agnes Medical Center, Fresno, California, United States

and more 115 locations

Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: Induction Carboplatin
Drug: Induction Paclitaxel
Procedure: Resection
Drug: Consolidation Carboplatin
Radiation: Radiation Therapy
Drug: Consolidation Paclitaxel

First Posted Date: 2004-11-09

Last Posted Date: 2019-09-18

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 60

Registration Number: NCT00096226

Locations: 🇺🇸
Arizona Oncology Services Foundation, Phoenix, Arizona, United States
🇺🇸
Virginia G. Piper Cancer Center at Scottsdale Healthcare - Shea, Scottsdale, Arizona, United States
🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States

and more 19 locations

Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: paclitaxel
Radiation: radiation therapy

First Posted Date: 2004-09-13

Last Posted Date: 2013-11-13

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 122

Registration Number: NCT00003591

Locations: 🇺🇸
Veterans Affairs Medical Center - Birmingham, Birmingham, Alabama, United States
🇺🇸
University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Huntsville Hospital System, Huntsville, Alabama, United States

and more 231 locations

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

First Posted Date: 2004-09-09

Last Posted Date: 2020-08-10

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 129

Registration Number: NCT00091390

Locations: 🇺🇸
Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States
🇺🇸
Cancer Care Consultants Medical Associates at Daniel Freeman Memorial Hospital, Inglewood, California, United States
🇺🇸
Radiological Associates of Sacramento Medical Group, Incorporated, Sacramento, California, United States

and more 9 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy